Growing community of inventors

Tucson, AZ, United States of America

Deborah Strootman

Average Co-Inventor Count = 3.58

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 196

Deborah StrootmanRoger Jeffs (4 patents)Deborah StrootmanMichael Wade (4 patents)Deborah StrootmanKathryn Bronstein (2 patents)Deborah StrootmanRobert Roscigno (1 patent)Deborah StrootmanRoger Andrew Jeffs (0 patent)Deborah StrootmanRoger Andrew Jeffs (1 patent)Deborah StrootmanMichael Wade (1 patent)Deborah StrootmanDeborah Strootman (4 patents)Roger JeffsRoger Jeffs (22 patents)Michael WadeMichael Wade (21 patents)Kathryn BronsteinKathryn Bronstein (2 patents)Robert RoscignoRobert Roscigno (7 patents)Roger Andrew JeffsRoger Andrew Jeffs (0 patent)Roger Andrew JeffsRoger Andrew Jeffs (3 patents)Michael WadeMichael Wade (10 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. United Therapeutics Corporation (4 from 126 patents)

2. Deborah Strootman (0 patent)

3. Roger Andrew Jeffs (0 patent)

4. Michael Wade (0 patent)


4 patents:

1. 8765813 - Use of treprostinil to treat and prevent ischemic lesions

2. 8563614 - Use of treprostinil to treat neuropathic diabetic foot ulcers

3. 7879909 - Use of Treprostinil to treat neuropathic diabetic foot ulcers

4. 7199157 - Use of treprostinil to improve kidney functions

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…